Impact of Venlafaxine on Platelet Count and Activity—Case Report and Narrative Review
Venlafaxine (VEN) is considered to be one of the most effective antidepressants. It belongs to the group of serotonin (5-HT) and noradrenaline (NA) reuptake inhibitors (SNRIs). NA and 5-HT have receptors on the surface of platelets and are involved in platelet aggregation. In this case study, we pre...
Main Authors: | Joanna Smolarczyk-Kosowska, Michał Kosowski, Łukasz Kunert, Karolina Filipczyk, Marcin Wojciechowski, Magdalena Piegza, Piotr Gorczyca, Bogusław Okopień, Robert Pudlo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/5/626 |
Similar Items
-
Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia
by: Caroline Vayne, et al.
Published: (2020-07-01) -
A Case of Vancomycin-Induced Severe Immune Thrombocytopenia
by: Shivani Shah, et al.
Published: (2023-04-01) -
Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation
by: Enzo Lüsebrink, et al.
Published: (2023-01-01) -
Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS
by: Emmanuel J. Favaloro, et al.
Published: (2022-01-01) -
Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
by: Hung-Chen Lin, et al.
Published: (2023-02-01)